These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3043876)

  • 41. Acute renal failure after intravenous urography: detection of antibodies against contrast media.
    Kleinknecht D; Deloux J; Homberg JC
    Clin Nephrol; 1974; 2(3):116-9. PubMed ID: 4850420
    [No Abstract]   [Full Text] [Related]  

  • 42. Pathophysiology of contrast medium-induced nephropathy.
    Persson PB; Hansell P; Liss P
    Kidney Int; 2005 Jul; 68(1):14-22. PubMed ID: 15954892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contrast-induced acute renal failure: persistent nephrogram as clue to early detection.
    Older RA; Korobkin M; Cleeve DM; Schaaf R; Thompson W
    AJR Am J Roentgenol; 1980 Feb; 134(2):339-42. PubMed ID: 6766243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-osmolality contrast media: a current perspective.
    King BF; Hartman GW; Williamson B; LeRoy AJ; Hattery RR
    Mayo Clin Proc; 1989 Aug; 64(8):976-85. PubMed ID: 2677533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?
    Katzberg RW; Newhouse JH
    Radiology; 2010 Jul; 256(1):21-8. PubMed ID: 20574082
    [No Abstract]   [Full Text] [Related]  

  • 46. Preclinical Studies of a Kidney Safe Iodinated Contrast Agent.
    Rowe ES; Rowe VD; Biswas S; Mosher G; Insisienmay L; Ozias MK; Gralinski MR; Hunter J; Barnett JS
    J Neuroimaging; 2016 Sep; 26(5):511-8. PubMed ID: 27171830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Newer contrast agents for urography.
    Spataro RF
    Radiol Clin North Am; 1984 Jun; 22(2):365-80. PubMed ID: 6205415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nephrotoxicity of low-osmolality contrast media.
    Laranja SM; Ajzen H; Schor N
    Ren Fail; 1997 Mar; 19(2):307-14. PubMed ID: 9101609
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nephrotoxicity of iodinated contrast products].
    Christin F; Pottecher T
    Ann Fr Anesth Reanim; 2000 Aug; 19(7):fi128-30. PubMed ID: 10976363
    [No Abstract]   [Full Text] [Related]  

  • 50. Nephrotoxicity of radiocontrast media in ischemic renal failure in rabbits.
    Sherwood T
    Nephron; 1983; 34(3):205. PubMed ID: 6877454
    [No Abstract]   [Full Text] [Related]  

  • 51. Decision analysis to assess cost-effectiveness of low-osmolality contrast medium for intravenous urography.
    Calvo MV; Pilar del Val M; Mar Alvarez M; Domínguez-Gil A
    Am J Hosp Pharm; 1992 Mar; 49(3):577-84. PubMed ID: 1598930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective use of low-osmolality contrast agents for i.v. urography and CT: safety and effect on cost.
    Hunter TB; Dye J; Duval JF
    AJR Am J Roentgenol; 1994 Oct; 163(4):965-8. PubMed ID: 8092044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Complications of osmotic nephrosis after perfusion urography in renal insufficiency].
    Kleinknecht D; Jungers P; Michel JR; Philippe B; Nabarra B; Hinglais N
    Ann Med Interne (Paris); 1971 Nov; 122(11):1167-71. PubMed ID: 5150320
    [No Abstract]   [Full Text] [Related]  

  • 54. Safety profile of new non-ionic contrast media: renal tolerance.
    Stacul F; Thomsen HS
    Eur J Radiol; 1996 Nov; 23 Suppl 1():S6-9. PubMed ID: 9056157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A micropuncture assessment of the effects of contrast media of different osmolality.
    Morsing P; Persson AE; Boberg U
    Invest Radiol; 1988 Oct; 23(10):767-71. PubMed ID: 3192398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urine profiles and kidney histology after intravenous injection of ionic and nonionic radiologic and magnetic resonance contrast media in normal rats.
    Thomsen HS; Dorph S; Larsen S; Horn T; Hemmingsen L; Skaarup P; Golman K; Svendsen O
    Acad Radiol; 1994 Oct; 1(2):128-35. PubMed ID: 9419476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Acute renal failure after gadolinium-containing contrast medium in preexisting chronic renal failure stage II].
    Jürgensen T; Brossmann J; Herrlinger JD
    Med Klin (Munich); 2007 Jun; 102(6):480-2. PubMed ID: 17571223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal tolerance of nonionic dimers.
    Deray G; Jacobs C
    Invest Radiol; 1996 Jun; 31(6):372-7. PubMed ID: 8761871
    [No Abstract]   [Full Text] [Related]  

  • 59. Nephrotoxicity of low osmolality contrast media versus high osmolality media.
    Steinberg EP; Moore RD; Brinker JA; Fishman EK; Powe NR; Graziano SL; Gopalan R
    Invest Radiol; 1991 Nov; 26 Suppl 1():S86; discussion S88-91. PubMed ID: 1808157
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of renal function before and after intravenous injection of uroangiographic water soluble contrast media in men.
    Verbaeys A; Lameire N; Oosterlinck W
    Acta Urol Belg; 1989; 57(4):795-801. PubMed ID: 2631582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.